SunMirror AG

  • ISIN: CH0396131929
  • Land: Schweiz

Nachricht vom 21.09.2020 | 11:34

SunMirror AG: Sphene Capital starts research coverage of SunMirror shares / Recommendation to buy, price target €68.90

DGAP-News: SunMirror AG / Key word(s): Miscellaneous
21.09.2020 / 11:34
The issuer is solely responsible for the content of this announcement.

SunMirror AG

Press release

Sphene Capital starts research coverage of SunMirror shares / Recommendation to buy, price target €68.90

Zug, Switzerland; 21 September 2020 - Munich-based research agency Sphene Capital has started to cover SunMirror AG. The analysts of the agency focusing on small and mid caps award a buy rating to SunMirror shares at a price target of €68.90. In doing so, the determination of the price target is based on a 50:50 mix of a sum-of-the-parts valuation, which Sphene Capital developed from the single assessment of SunMirror's three commodity assets, and publicly available valuation reports dealing with the three raw material regions concerned.

The analysts arrived at the conclusion that particular strengths are inherent in SunMirror's strategy to exclusively acquire investments in developed countries, thereby avoiding country-specific risks in politically instable regions.

The entire report will be available in the course of the day on SunMirror AG's website at and also at

About SunMirror AG
Founded in 2017, SunMirror AG is a strategic equity investment company for natural resources focusing on gold and other metals and minerals powering demand for sustainable next-generation technologies.

About Sphene Capital:
Founded in 2010, Sphene Capital GmbH has positioned itself as the quality leader among German research agencies. The agency's initiation reports usually have between 40 and 80 pages, while the event-driven updates that the agency will publish about SunMirror following each of the latter's relevant corporate press releases will have between eight and 30 pages. In addition, Sphene Capital attaches great importance to the exact wording of its equity stories, a thorough understanding of market and competition as well as well-founded and error-free company valuations. Two years ago Sphene Capital was selected by Euronext as its exclusive research partner for all companies listed at Euronext Frankfurt which operate in the areas of biotech/pharmaceuticals, internet and technology.

Press contact
edicto GmbH
Doron Kaufmann
Tel.: +49 69 905505-53
Eschersheimer Landstraße 42-44
60322 Frankfurt a.M.

21.09.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

show this

Event im Fokus

14.-15.10.2020 Fachkonferenzen Finanzdienstleistungen und Technologie

11.-12.11.2020 Fachkonferenzen Software/IT und Branchenmix

Je nach aktueller Covid-19 Situation und den bestehenden Vorschriften für Versammlungen könnten die Fachkonferenzen im Herbst/Winter ggf. auch virtuell stattfinden.


Solutiance: Hohe Wachstumsdynamik durch den Ausbau des Plattformgeschäfts erwartet

Im ersten Halbjahr 2020 konnte Solutiance den eingeschlagenen Wachstumskurs fortsetzen und im Rahmen dessen die Gesamtleistung (Umsatz zzgl. Bestandsveränderungen) um rund 75 % auf 0,66 Mio. € (1. HJ 2019: 0,38 Mio. €) erhöhen. Das Unternehmen erwartet für das Gesamtjahr durch den weiteren Ausbau der softwarebasierten Dienstleistungen einen Umsatzsprung im Vergleich zum Vorjahr auf rund 3 Mio. €. Bei einem von uns ermittelten Kursziel von 4,85 € vergeben wir das Rating KAUFEN.

News im Fokus

Munich Re erzielt Quartalsergebnis von ca. 200 Mio. €

20. Oktober 2020, 15:37

Aktuelle Research-Studie

CytoTools AG

Original-Research: CytoTools AG (von BankM AG): Kaufen

19. Oktober 2020